Company Overview

PRIME exits® and American Health Care Capital are pleased to exclusively present a full-service ophthalmology practice for sale providing medical, surgical, and preventive eye care. Operating from two offices in Southern California, the practice maintains consistent weekday hours (8:00 a.m. – 5:00 p.m.) and holds a 4.1–4.2-star rating across major review platforms, reflecting strong patient satisfaction and community trust. While their current service area is concentrated within one county, the model offers clear opportunities for geographic expansion. The practice has built long-standing referral relationships with local physicians, hospitals, and families and provides comprehensive services including pediatric eye care, cataract treatment, glaucoma care, retina evaluation, oculoplastics, and routine eye exams. Services are composed of approximately 50% exams and office visits, 25% surgical procedures, and 25% in-office procedures, supporting a well-balanced revenue mix and positioning the group as a trusted regional provider of specialty ophthalmic care.

Payers & Referrals

The payor sources are 50% Medical Insurance, 30% Medicare, and 20% HMO/PPO. AEI receives a steady stream of referral patients from primary care physicians, medical groups, hospitals, and insurance companies.

Key Strengths

• Experienced ophthalmologists with strong patient endorsements for diagnostic accuracy, surgical expertise, and attentive follow-up care.

• Modern clinical infrastructure with efficient patient intake, online forms, and streamlined scheduling.

• Comprehensive care model allowing evaluation, treatment, surgery, and postoperative management within a single practice.The practice is recognized for professionalism, clear communication, and strong surgical outcomes, with consistently high patient satisfaction. Its long-standing community presence, integrated care delivery, and reputation for quality service position the group as a trusted regional provider of specialty eye care.

Financial Information

For the years 2023 and 2024, the practice was mismanaged by partners who are no longer with the practice. The partners who mismanaged the practice were doing a bad job with expenses and marketing for new business. As a result of their departure expenses are under control and top line growth has improved and 2025 and beyond have looked much brighterIn 2023, the company had a Gross Revenue of $2,120,203 with an EBITDA of $619,424. In 2024, the company had Gross Revenue of $2,246,246 with EBITDA of $203,957. In 2025, they had Gross Revenue of $2,981,457 with EBITDA of $902,594. For 2026, they are on track for Gross Revenue of $3,300,000.

Growth Potential

A new owner could renegotiate contracts with existing insurance providers to add to top line by 15% or more. In addition, adding another MD Surgeon would be a prudent step in increasing growth.

Staff Overview

The staff consists of the owner who is an MD plus 2 additional MDs and 2 Doctors of Optometry for a total of 5 MDs. an office manager and 13 other support staff. The principal and all staff are expected to stay on board post sale.

Asking Price & Exit Plan

The asking price for this business is $4.5 million. The owner is willing to stay active for a negotiable time to ensure a smooth transition.